Literature DB >> 19093118

Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis with cryptogenic organizing pneumonia in invasive breast cancer: a case report and review of literature.

Sung Hwan Park1, Yoon-Seup Kum, Kyung-Chan Kim, Jung-Yoon Choe, Sung-Hoon Park, Seong-Kyu Kim.   

Abstract

Amyopathic dermatomyositis (ADM) is recognized as a variant phenotype of dermatomyositis and characterized by typical skin manifestations without evidence of muscular inflammation. While interstitial lung disease (ILD) is occasionally found as one of the lung manifestations in ADM patients, the development of a pneumomediastinum and/or subcutaneous emphysema in this disease entity is one of the extremely rare pulmonary complications. These latter complicated pulmonary manifestations have been usually reported in idiopathic ADM with ILD without any other associated medical conditions. We report a case presented with the spontaneous pneumomediastinum and subcutaneous emphysema in both ADM and cryptogenic organizing pneumonia during adjuvant chemotherapy based on cyclophosphamide for breast cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19093118     DOI: 10.1007/s00296-008-0808-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  19 in total

1.  A 34-year-old man with amyopathic dermatomyositis and rapidly progressive dyspnea with facial swelling. Diagnosis: pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis-associated interstitial lung disease.

Authors:  Christian Powell; Brian Kendall; Richard Wernick; John E Heffner
Journal:  Chest       Date:  2007-11       Impact factor: 9.410

2.  Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis.

Authors:  Eishi Miyazaki; Masaru Ando; Tomoko Muramatsu; Tetsujiro Fukami; Osamu Matsuno; Shin-Ichi Nureki; Takuya Ueno; Tomiyasu Tsuda; Toshihide Kumamoto
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

3.  Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.

Authors:  B Sigurgeirsson; B Lindelöf; O Edhag; E Allander
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

4.  Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis.

Authors:  Spyros Aslanidis; Athina Pyrpasopoulou; Nikoleta Kartali; Chryssanthos Zamboulis
Journal:  Clin Rheumatol       Date:  2006-05-31       Impact factor: 2.980

5.  Amyopathic dermatomyositis: a review by the Italian Group of Immunodermatology.

Authors:  Marzia Caproni; Carla Cardinali; Aurora Parodi; Barbara Giomi; Manuela Papini; Mario Vaccaro; Angelo Marzano; Clara De Simone; Marcello Fazio; Alfredo Rebora; Paolo Fabbri
Journal:  Arch Dermatol       Date:  2002-01

6.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

Authors:  C L Hill; Y Zhang; B Sigurgeirsson; E Pukkala; L Mellemkjaer; A Airio; S R Evans; D T Felson
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

7.  Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.

Authors:  E H Kang; E B Lee; K C Shin; C H Im; D H Chung; S K Han; Y W Song
Journal:  Rheumatology (Oxford)       Date:  2005-06-21       Impact factor: 7.580

8.  Interstitial lung disease associated with amyopathic dermatomyositis: review of 18 cases.

Authors:  Gen Ideura; Masayuki Hanaoka; Tomonobu Koizumi; Keisaku Fujimoto; Yasuhiro Shimojima; Wataru Ishii; Masayuki Matsuda; Shuichi Ikeda
Journal:  Respir Med       Date:  2007-03-13       Impact factor: 3.415

Review 9.  A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.

Authors:  Pedram Gerami; Jennifer M Schope; Lauren McDonald; Hobart W Walling; Richard D Sontheimer
Journal:  J Am Acad Dermatol       Date:  2006-01-23       Impact factor: 11.527

Review 10.  Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature.

Authors:  Ken Yoshida; Daitaro Kurosaka; Isamu Kingetsu; Kenichiro Hirai; Akio Yamada
Journal:  Rheumatol Int       Date:  2008-02-29       Impact factor: 2.631

View more
  3 in total

Review 1.  Bronchiolitis obliterans organizing pneumonia in patients with autoimmune rheumatic diseases.

Authors:  Carmen Maria Lara Rojas; Elisabetta Borella; Lavinia Palma; Silvio Ragozzino; Enrique De Ramón; Ricardo Gomez-Huelgas; Leonardo Punzi; Andrea Doria
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  Cavitary lung cancer presenting as subcutaneous emphysema on the contralateral side.

Authors:  Serhat Yalçinkaya; Ahmet Hakan Vural; Mehmet Tugrul Göncü; Ahmet Fatih Özyazicioglu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-12-07

Review 3.  Cryptogenic organizing pneumonia associated with invasive pulmonary aspergillosis: a case report and review of the literature.

Authors:  Shuanshuan Xie; Changxing Shen; Yunfeng Zhang; Kun Lu; Feng Hu; Min Tan; Haiyan Lin; Lei Xu; Qing Yuan; Xiaolian Song; Changhui Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.